IMSI (Intracytoplasmic Morphologically Selected Sperm Injection) is an advanced version of ICSI that uses 6,000× magnification (vs 200× for standard ICSI) to select sperm with the most normal internal structure before injection. At Mother Hospitals, Boduppal, IMSI is available for couples with severe teratospermia or high DNA fragmentation. Call 97059 93366.
When standard ICSI is not enough — IMSI at Mother Hospitals, Boduppal uses 6,000× magnification to examine and select the best-structured sperm before injection. Available for severe male factor infertility, high DNA fragmentation, and previous ICSI failures. One of the few centres in Hyderabad offering this advanced technique.

MBBS, DGO, PG Diploma in ART – Kiel University, Germany | 20+ Years Experience | TGMC Reg: 50624
IMSI — Intracytoplasmic Morphologically Selected Sperm Injection — is an enhanced version of the standard ICSI technique. The critical difference is magnification: IMSI uses an inverted microscope with Nomarski differential interference contrast (DIC) optics to examine sperm at 6,000× magnification before selection and injection. This is the MSOME method — Motile Sperm Organelle Morphology Examination.
In standard ICSI, sperm are selected under 200–400× magnification — enough to assess basic shape and motility but not internal structure. At this magnification, subtle abnormalities inside the sperm head (particularly vacuoles in the post-acrosomal region) are invisible. IMSI uses 6,000× magnification — 15–30 times more powerful than standard ICSI — allowing the embryologist to visualise the internal ultrastructure of each sperm in real time, without staining or fixation. Only structurally normal sperm with no significant vacuoles are selected for injection.
At 6,000× (MSOME), the embryologist can examine: the sperm head shape and symmetry, the acrosome (the cap that enables egg penetration), the post-acrosomal region for vacuoles, the mid-piece (energy-producing section), and the flagellum (tail). Sperm vacuoles — particularly large ones in the head — are associated with DNA damage and poor embryo development. At standard ICSI magnification, these vacuoles are completely invisible. IMSI allows their systematic exclusion from selection.
IMSI is not recommended for all IVF patients — the additional time and cost is justified in specific clinical situations where standard ICSI has limitations.
The IMSI procedure is part of your IVF cycle. The ovarian stimulation, egg retrieval, and embryo culture steps are identical to standard IVF/ICSI — the difference lies entirely in the sperm selection step performed by the embryologist.
The semen sample is prepared by density gradient centrifugation or swim-up technique on the day of egg retrieval, removing dead cells, debris, and seminal plasma. The prepared sample is concentrated in a small volume of culture medium.
Individual sperm from the prepared sample are placed under the MSOME microscope — an inverted microscope fitted with Nomarski differential interference contrast optics capable of 6,000× magnification. Each sperm is examined systematically: head shape, acrosome integrity, presence and size of vacuoles in the post-acrosomal region, mid-piece, and tail.
Sperm with large vacuoles — especially in the post-acrosomal region — are excluded from selection. Only sperm meeting strict morphological criteria at high magnification (normal head, no significant vacuoles, intact mid-piece, normal tail) are chosen for injection. This selection process takes longer than standard ICSI sperm selection.
The selected sperm is aspirated into an injection pipette and injected into each mature (MII-stage) egg — identical to the standard ICSI injection technique. The IMSI advantage is entirely in the selection step; the injection itself is the same micromanipulation procedure used in ICSI.
Fertilisation is confirmed at 16–18 hours post-injection (2 pronuclei). Embryos are cultured in time-lapse incubators or standard incubators to Day 3 (cleavage) or Day 5/6 (blastocyst). Best-quality embryos are selected for transfer or vitrification — the embryo culture and selection process is identical to standard IVF/ICSI.
Sperm DNA fragmentation (measured as the DNA Fragmentation Index, or DFI) refers to breaks or damage in the DNA strands carried within the sperm head. A DFI above 15–25% is associated with reduced fertilisation rates, poorer embryo development, increased miscarriage rates, and lower IVF success. DNA fragmentation is not assessed in a routine semen analysis — it requires a dedicated sperm DNA fragmentation test (TUNEL, COMET, or SCD assay). See our full guide to sperm DNA fragmentation for detailed information.
The evidence is promising but not yet definitive for all patients. The biological rationale is sound: sperm vacuoles (visible at 6,000×) correlate with nuclear DNA damage, so excluding vacuole-bearing sperm may enrich the selected pool for lower-DFI individuals. Several studies show improved fertilisation rates and embryo quality with IMSI in high-DFI cases. However, large randomised controlled trials are limited, and the benefit appears most clear in men with severe teratospermia. At Mother Hospitals, we discuss the evidence honestly with each couple before recommending IMSI.
Three sperm selection techniques are available for IVF couples with male factor infertility. Here's how they compare.
✦ Technique suitability is assessed individually. Dr. E. Prashanthi Reddy will recommend the most appropriate sperm selection approach for your specific case at consultation.
We believe in evidence-based medicine and honest patient counselling. Here is what the science currently says about IMSI outcomes.
Meta-analyses and systematic reviews show the clearest benefit of IMSI in men with severe teratospermia (Kruger strict morphology below 1%) and in couples with previous ICSI failure attributed to poor embryo quality. In these groups, IMSI is associated with improved fertilisation rates, higher-quality embryo development, and in some studies, better clinical pregnancy rates per transfer. The benefit is biologically plausible: when morphology is severely abnormal, the additional scrutiny at 6,000× adds real discriminating power.
For unselected IVF couples (normal or mildly abnormal semen parameters), randomised controlled trials have generally not demonstrated that IMSI improves outcomes over standard ICSI. A Cochrane systematic review noted limited high-quality evidence for IMSI in unselected patients. This means IMSI is not recommended for everyone — and at Mother Hospitals, we only recommend it where there is a genuine clinical indication. Adding IMSI in cases without a clear indication adds cost and laboratory time without a proven benefit.
Our position: IMSI is a valuable tool for the right patients — those with severe teratospermia, high DNA fragmentation, or previous unexplained ICSI failure. For couples with normal or mildly abnormal semen parameters, standard ICSI remains the evidence-based choice. Dr. E. Prashanthi Reddy will discuss your individual case honestly and recommend IMSI only when it is genuinely likely to add value to your treatment.
IMSI is offered as an add-on to a standard IVF/ICSI cycle at Mother Hospitals. The additional cost reflects the specialist equipment (MSOME microscope) and the increased embryologist time required for high-magnification sperm selection.
IMSI is charged as an addition to the standard IVF + ICSI package. The fee covers embryologist time, MSOME microscope use, and the extended sperm selection process. Contact us for the current fee schedule.
The base IVF + ICSI cycle cost covers stimulation protocol, monitoring, egg retrieval, embryo culture to blastocyst, and transfer. IMSI is added on top of this package when indicated.
For the right patients — severe teratospermia, high DFI, previous ICSI failure — yes. The marginal cost of IMSI is modest relative to the total IVF cycle cost, and the potential benefit in selected cases is meaningful. Discuss whether IMSI is indicated in your case at consultation.
Not all IVF centres in Hyderabad have the specialist MSOME microscope equipment required for true 6,000× IMSI. Mother Hospitals has this capability — IMSI is offered as a genuine clinical service, not a marketing term.
IMSI requires a highly skilled embryologist — the extended selection process at high magnification demands precision and experience. Our embryology team is trained in MSOME assessment and IMSI technique.
We do not recommend IMSI for every patient — only where there is a genuine evidence-based indication. This protects you from unnecessary cost and ensures IMSI is used where it may actually make a difference to your outcome.
IMSI at Mother Hospitals is part of a comprehensive male infertility pathway — including semen analysis, DNA fragmentation testing, TESA/PESA, antioxidant therapy, and ICSI. Your treatment is planned holistically.
All procedures at Mother Hospitals, including IMSI, are conducted under the ART Act 2021 regulatory framework. Consent documentation and laboratory practices meet the required standards.
With 20+ years of IVF experience and over 10,000 families helped, Mother Hospitals brings depth of clinical experience to every case — including the most complex male factor infertility situations.
ICSI (Intracytoplasmic Sperm Injection) is the standard technique of injecting a single sperm into each egg at 200–400× magnification — selecting by basic shape and motility. IMSI (Intracytoplasmic Morphologically Selected Sperm Injection) performs the same injection but selects sperm at 6,000× magnification using the MSOME technique — examining internal sperm structure, especially the presence of vacuoles in the sperm head. IMSI takes longer and requires specialist equipment but may select a structurally better sperm in cases with severe morphology problems.
Not for everyone. IMSI is better than standard ICSI in specific patients — particularly those with severe teratospermia and high sperm DNA fragmentation — where the additional selection scrutiny appears to improve fertilisation rates and embryo quality. For patients with normal or mildly abnormal semen parameters, published evidence does not show a consistent benefit of IMSI over standard ICSI. The right technique for you depends on your individual semen analysis and clinical history.
No. IMSI is not recommended for unselected IVF patients. Current evidence and international guidelines do not support routine IMSI for all couples — the benefit is specific to men with severe teratospermia, high DNA fragmentation, or unexplained previous ICSI failure. Recommending IMSI for everyone would add cost without improving outcomes for most patients. At Mother Hospitals, we recommend IMSI only where it is clinically indicated.
The sperm selection phase of IMSI takes considerably longer than standard ICSI — because each sperm is examined at 6,000× magnification and assessed against strict morphological criteria before selection. Depending on the number of eggs and the characteristics of the sperm sample, IMSI may add 1–3 hours to the embryologist's laboratory time on the day of egg collection. This is factored into the procedure planning. The injection itself takes the same time as standard ICSI once the sperm are selected.
No. True IMSI requires a specialised MSOME microscope with Nomarski DIC optics capable of 6,000× magnification — not all IVF laboratories have this equipment. Some centres may offer "high-magnification ICSI" or similar services without the specific MSOME microscope system. At Mother Hospitals, Boduppal, IMSI is performed using the proper MSOME equipment by trained embryologists. Always confirm the specific equipment and training before proceeding with IMSI at any centre.
A sperm vacuole is a membrane-bound cavity or pocket within the sperm head — particularly in the nucleus and post-acrosomal region. Vacuoles are invisible at standard ICSI magnification (200–400×) but become visible at 6,000× under MSOME assessment. Large vacuoles in the post-acrosomal region are associated with chromatin abnormalities and DNA damage. The IMSI selection criterion specifically excludes sperm with vacuoles occupying more than a defined percentage of the sperm head, aiming to select sperm with better chromatin integrity.
Yes — IMSI is one of the options to consider after failed ICSI cycles, particularly if poor embryo quality or fertilisation failure was the issue and the semen sample showed severe morphology abnormalities or high DNA fragmentation. Upgrading from standard ICSI to IMSI, combined with other interventions (antioxidant therapy, optimising sperm preparation), may improve embryo development in subsequent cycles. Dr. E. Prashanthi Reddy will review your previous cycle outcomes and advise on the most appropriate changes for the next attempt.
Yes — IMSI has an additional cost over standard ICSI, reflecting the specialist MSOME microscope equipment and the significantly increased embryologist time required for high-magnification sperm selection. The exact fee depends on the number of eggs and the complexity of the case. Contact Mother Hospitals on 97059 93366 or WhatsApp for current pricing. For patients where IMSI is clinically indicated, the additional cost is modest relative to the total IVF cycle investment.
Dr. E. Prashanthi Reddy · TGMC Reg: 50624